
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Medication use patterns and polypharmacy among elderly in Iran: a cross-sectional study using national health insurance claims data - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152532258AF152130532250057A66876.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmjo">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374635/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMJ Open">
<meta name="citation_title" content="Medication use patterns and polypharmacy among elderly in Iran: a cross-sectional study using national health insurance claims data">
<meta name="citation_author" content="Seyed Mohammad-Navid Ataei">
<meta name="citation_author_institution" content="Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Ali Golestani">
<meta name="citation_author_institution" content="Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Sepehr Khosravi">
<meta name="citation_author_institution" content="Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Ozra Tabatabaei-Malazy">
<meta name="citation_author_institution" content="Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Mohammad-Reza Malekpour">
<meta name="citation_author_institution" content="Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Mahbube Ebrahimpur">
<meta name="citation_author_institution" content="Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Fatemeh Sadat Mirzadeh">
<meta name="citation_author_institution" content="Clinical Gerontology &amp; Geriatric Department, Medical School, Tehran University of Medical Sciences, Ziaeian Hospital, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Zahra Shahali">
<meta name="citation_author_institution" content="National Center for Health Insurance Research, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Mohammad Reza Amini">
<meta name="citation_author_institution" content="Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author" content="Mohammad Effatpanah">
<meta name="citation_author_institution" content="National Center for Health Insurance Research, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_author_institution" content="School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="15">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e097863">
<meta name="citation_doi" content="10.1136/bmjopen-2024-097863">
<meta name="citation_pmid" content="40840984">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374635/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374635/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374635/pdf/bmjopen-15-8.pdf">
<meta name="description" content="Polypharmacy, defined as the concurrent use of multiple medications, is a growing concern among the elderly, especially in low-income and middle-income countries such as Iran. This study aims to explore the prevalence and patterns of polypharmacy ...">
<meta name="og:title" content="Medication use patterns and polypharmacy among elderly in Iran: a cross-sectional study using national health insurance claims data">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Polypharmacy, defined as the concurrent use of multiple medications, is a growing concern among the elderly, especially in low-income and middle-income countries such as Iran. This study aims to explore the prevalence and patterns of polypharmacy ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374635/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374635">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1136/bmjopen-2024-097863"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/bmjopen-15-8.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374635%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374635/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374635/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374635/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmjopen.png" alt="BMJ Open logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMJ Open" title="Link to BMJ Open" shape="default" href="http://bmjopen.bmj.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMJ Open</button></div>. 2025 Aug 21;15(8):e097863. doi: <a href="https://doi.org/10.1136/bmjopen-2024-097863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1136/bmjopen-2024-097863</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMJ%20Open%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMJ%20Open%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMJ%20Open%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMJ%20Open%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Medication use patterns and polypharmacy among elderly in Iran: a cross-sectional study using national health insurance claims data</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ataei%20SMN%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Seyed Mohammad-Navid Ataei</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Seyed Mohammad-Navid Ataei</span></h3>
<div class="p">
<sup>1</sup>Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ataei%20SMN%22%5BAuthor%5D" class="usa-link"><span class="name western">Seyed Mohammad-Navid Ataei</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Golestani%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Ali Golestani</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Ali Golestani</span></h3>
<div class="p">
<sup>1</sup>Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Golestani%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali Golestani</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khosravi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Sepehr Khosravi</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Sepehr Khosravi</span></h3>
<div class="p">
<sup>1</sup>Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khosravi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sepehr Khosravi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tabatabaei-Malazy%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ozra Tabatabaei-Malazy</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ozra Tabatabaei-Malazy</span></h3>
<div class="p">
<sup>2</sup>Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tabatabaei-Malazy%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Ozra Tabatabaei-Malazy</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Malekpour%20MR%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Mohammad-Reza Malekpour</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Mohammad-Reza Malekpour</span></h3>
<div class="p">
<sup>1</sup>Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Malekpour%20MR%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohammad-Reza Malekpour</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ebrahimpur%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Mahbube Ebrahimpur</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Mahbube Ebrahimpur</span></h3>
<div class="p">
<sup>3</sup>Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ebrahimpur%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mahbube Ebrahimpur</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mirzadeh%20FS%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Fatemeh Sadat Mirzadeh</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Fatemeh Sadat Mirzadeh</span></h3>
<div class="p">
<sup>4</sup>Clinical Gerontology &amp; Geriatric Department, Medical School, Tehran University of Medical Sciences, Ziaeian Hospital, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mirzadeh%20FS%22%5BAuthor%5D" class="usa-link"><span class="name western">Fatemeh Sadat Mirzadeh</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shahali%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Zahra Shahali</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Zahra Shahali</span></h3>
<div class="p">
<sup>5</sup>National Center for Health Insurance Research, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shahali%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zahra Shahali</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amini%20MR%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Mohammad Reza Amini</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Mohammad Reza Amini</span></h3>
<div class="p">
<sup>6</sup>Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amini%20MR%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohammad Reza Amini</span></a>
</div>
</div>
<sup>6,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Effatpanah%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Mohammad Effatpanah</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Mohammad Effatpanah</span></h3>
<div class="p">
<sup>5</sup>National Center for Health Insurance Research, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">
<sup>7</sup>School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Effatpanah%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohammad Effatpanah</span></a>
</div>
</div>
<sup>5,</sup><sup>7,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div id="aff2">
<sup>2</sup>Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div id="aff3">
<sup>3</sup>Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div id="aff4">
<sup>4</sup>Clinical Gerontology &amp; Geriatric Department, Medical School, Tehran University of Medical Sciences, Ziaeian Hospital, Tehran, Iran (the Islamic Republic of)</div>
<div id="aff5">
<sup>5</sup>National Center for Health Insurance Research, Tehran, Iran (the Islamic Republic of)</div>
<div id="aff6">
<sup>6</sup>Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div id="aff7">
<sup>7</sup>School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Dr Mohammad Reza Amini; <span>mramini@tums.ac.ir</span></p>
</div>
<div class="fn" id="cor2">
<sup>*</sup><p class="display-inline">Dr Mohammad Effatpanah; <span>m.effatpanah@gmail.com</span></p>
</div>
<div class="fn" id="fn5"><p>None declared.</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Dec 11; Accepted 2025 Jul 24; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</div>
<p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374635  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40840984/" class="usa-link">40840984</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title"> Abstract</h3></section><section id="sec2"><h3 class="pmc_sec_title">Objectives</h3>
<p>Polypharmacy, defined as the concurrent use of multiple medications, is a growing concern among the elderly, especially in low-income and middle-income countries such as Iran. This study aims to explore the prevalence and patterns of polypharmacy among the elderly in Iran, using health insurance claims data to identify common drug classes and coprescribed medications, with a focus on informing policy decisions and improving medication management.</p></section><section id="sec3"><h3 class="pmc_sec_title">Design</h3>
<p>Retrospective population-based observational study.</p></section><section id="sec4"><h3 class="pmc_sec_title">Setting</h3>
<p>Nationwide data from the Iran Health Insurance Organization (IHIO) across 24 provinces.</p></section><section id="sec5"><h3 class="pmc_sec_title">Participants</h3>
<p>1 876 527 individuals aged 65 years and older, insured by the IHIO from 2014 to 2017. Individuals with incomplete demographic information or lacking medication records in the database were excluded from the analysis.</p></section><section id="sec6"><h3 class="pmc_sec_title">Primary and secondary outcome measures</h3>
<p>Prevalence and patterns of polypharmacy, demographic factors associated with polypharmacy, and common drug classes used. Medications were classified using the Anatomical Therapeutic Chemical system. Polypharmacy was defined as the use of five or more medications, with cumulative polypharmacy considering total drug use over time, and consecutive polypharmacy focusing on the frequency of monthly drug use. Logistic regression and association rule mining were applied to explore demographic factors and medication patterns associated with polypharmacy.</p></section><section id="sec7"><h3 class="pmc_sec_title">Results</h3>
<p>Of the study population, 74.9% experienced cumulative polypharmacy over 6 months and 64.6% over 1 month, with 7.6% experiencing consecutive polypharmacy. Females and those aged 75–79 were more prone to polypharmacy. Systemic glucocorticoids were the most commonly used medications (50.02%), followed by HMG-CoA reductase inhibitors (42.73%) and platelet aggregation inhibitors (41.92%). Polypharmacy was most strongly associated with medications related to the alimentary tract and metabolism, cardiovascular system, nervous system and blood and blood-forming organs.</p></section><section id="sec8"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Polypharmacy is highly prevalent among the elderly in Iran, with significant variations by gender, age, insurance fund and region. The findings highlight the need for targeted interventions to manage polypharmacy and improve medication safety in this population.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Aged, Polypharmacy, Prescriptions, Prevalence</p></section></section><hr class="headless">
<section class="bt xbox font-sm" id="BX1"><h2 class="obj_head">Strengths and limitations of this study.</h2>
<ul class="list" style="list-style-type:disc">
<li><p>This study used a large, nationwide dataset covering 38% of the Iranian elderly population, providing robust statistical power.</p></li>
<li><p>Cumulative and consecutive definitions of polypharmacy were employed, capturing different dimensions of medication use.</p></li>
<li><p>Association rule mining provided novel insights into common drug combinations and their implications for polypharmacy.</p></li>
<li><p>Limitations include the use of claims data lacking clinical details, such as adherence and reasons for prescriptions.</p></li>
<li><p>Our analysis did not account for non-prescription medications, such as over-the-counter drugs and herbal supplements, which may lead to an underestimation of polypharmacy prevalence.</p></li>
</ul></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p> Polypharmacy, defined by the WHO as the concurrent use of multiple medications, is a major public health concern worldwide.<a href="#R1" class="usa-link" aria-describedby="R1"><sup>1</sup></a> This issue is particularly pronounced among the elderly and hospitalised patients.<a href="#R2" class="usa-link" aria-describedby="R2"><sup>2</sup></a> Various studies have documented differing levels of polypharmacy prevalence, influenced by study design, the thresholds used, the time frame and the populations examined. Among the elderly, the prevalence of polypharmacy can vary dramatically, ranging from 4% in outpatient settings to over 96.5% in inpatient settings.<a href="#R3" class="usa-link" aria-describedby="R3"><sup>3</sup></a> Key factors contributing to polypharmacy include older age, the presence of multiple comorbidities, poor self-perceived health status, physical activity limitations, depression and pain. Cardiovascular drugs are among the most commonly prescribed medications in this demographic.<a href="#R4" class="usa-link" aria-describedby="R4"><sup>4</sup></a></p>
<p>The implications of polypharmacy are extensive and multifaceted. From a medicines management perspective, polypharmacy is associated with challenges such as non-adherence, increased risk of drug interactions, medication errors and inappropriate prescribing practices. These issues not only complicate patient care but also contribute to increased healthcare utilisation, reflected in higher hospitalisation rates and medical costs. Adverse health outcomes linked to polypharmacy include falls, malnutrition, frailty, disability, functional decline and adverse drug events.<a href="#R5" class="usa-link" aria-describedby="R5"><sup>5 6</sup></a></p>
<p>In low-income and lower-middle-income countries such as Iran, the financial burden of pharmaceuticals is particularly pronounced, with a substantial portion of health expenditures allocated to medications.<a href="#R7" class="usa-link" aria-describedby="R7"><sup>7</sup></a> The WHO estimates that over half of all medicines are prescribed, dispensed or sold inappropriately, and that a similar proportion of patients fail to use medications correctly.<a href="#R8" class="usa-link" aria-describedby="R8"><sup>8</sup></a> This inappropriate use of medicines, which includes polypharmacy<a href="#R9" class="usa-link" aria-describedby="R9"><sup>9 10</sup></a> as well as the overuse of antibiotics, corticosteroids and injectable drugs,<a href="#R11" class="usa-link" aria-describedby="R11"><sup>11</sup></a> leads to significant wastage of resources and poses extensive health risks.<a href="#R8" class="usa-link" aria-describedby="R8"><sup>8</sup></a></p>
<p>As populations age, the prevalence of multiple chronic conditions increases, making older adults more susceptible to drug-related problems such as polypharmacy, inappropriate medication use and adverse drug reactions.<a href="#R12" class="usa-link" aria-describedby="R12"><sup>12</sup></a> Iran’s ageing population underscores the growing need for effective pharmaceutical management and equitable access to necessary medications. Healthcare systems must prioritise policies that promote the appropriate use of medications and monitor polypharmacy trends.<a href="#R7" class="usa-link" aria-describedby="R7"><sup>7</sup></a></p>
<p>Understanding the prevalence and patterns of polypharmacy is essential for developing strategies to manage this issue effectively. The Iran Health Insurance Organisation (IHIO), one of the principal insurers in Iran, covers about 50% of the population,<a href="#R13" class="usa-link" aria-describedby="R13"><sup>13</sup></a> offering a valuable resource for large-scale data analysis. Using health insurance claims data provides a cost-effective method to investigate medication use patterns and polypharmacy across different demographics and regions. This study aims to explore the prevalence of polypharmacy and identify the most frequently used drug classes and coprescribed medications among the elderly in Iran, using health insurance claims data from 2012 to 2015. These insights are crucial for informing policy decisions and improving medication management systems to enhance patient outcomes and achieve sustainable development.</p></section><section id="s2"><h2 class="pmc_sec_title">Methods</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Study design and population</h3>
<p>This retrospective population-based observational study analysed prescription data extracted from health insurance claims of individuals aged 65 years and older who were insured by the IHIO across 24 provinces of Iran. The study encompassed a period from 21 March 2014 to 19 March 2017. In total, 19 726 266 prescription records were extracted, representing data from 1 876 527 elderly individuals with complete demographic information and medication records. According to the 2016 census, there were 4 871 518 people aged 65 and older in Iran.<a href="#R14" class="usa-link" aria-describedby="R14"><sup>14</sup></a> Therefore, this study covered approximately 38% of the Iranian elderly population.</p>
<p>The IHIO has five main insurance funds: the Civil Servants Fund, which covers all civil servants including employed, retired and pensioned individuals; the Rural Fund, which includes villagers, nomads and residents of cities with populations under 20 000; the Iranian and Universal Health Insurance Funds, available to all Iranians either through full premium payment or based on household income; the Foreign Citizens Fund, for non-Iranian nationals; and the Other Social Strata Fund, which covers veterans, warfare victims, students, disabled individuals, welfare recipients and prisoners and their families.<a href="#R13" class="usa-link" aria-describedby="R13"><sup>13</sup></a></p></section><section id="s2-2"><h3 class="pmc_sec_title">Data collection and preparation</h3>
<p>The extracted data incorporated individuals’ date of birth, sex, province of residence, insurance fund, prescription date and medication records. Each insured individual was identified by a unique anonymised code, facilitating identification of multiple prescriptions for the same individual. As part of the data preparation process, we assessed the completeness of demographic variables and medication records in the database, which led to the exclusion of 3341 individuals with missing birth dates. To ensure the accuracy of age classification, we calculated individuals’ ages based on their date of birth relative to the prescription date. Only prescriptions where the recipient was aged 65 or older at the time of each prescription were included for analysis.</p>
<p>Medication records included details such as dosage, route of administration, form and package number. Medications were classified according to the Anatomical Therapeutic Chemical (ATC) classification system. This internationally recognised system categorises active substances into groups based on their therapeutic, pharmacological and chemical properties across five hierarchical levels. The first level (ATC-1) consists of main anatomical or pharmacological groups: alimentary tract and metabolism (A), blood and blood-forming organs (B), cardiovascular system (C), dermatologicals (D), genitourinary system and sex hormones (G), systemic hormonal preparations excluding sex hormones and insulins (H), anti-infectives for systemic use (J), antineoplastic and immunomodulating agents (L), musculo-skeletal system (M), nervous system (N), antiparasitic products, insecticides and repellents (P), respiratory system (R), sensory organs (S) and various (V). Each of these groups is divided into second-level categories, which are further detailed into third and fourth levels representing more specific pharmacological or chemical subgroups. The fifth level (ATC-5) identifies the precise chemical substance.<a href="#R15" class="usa-link" aria-describedby="R15"><sup>15</sup></a></p>
<p>Our dataset initially included a broad spectrum of medications. However, after careful consideration and in consultation with an expert panel in gerontology, internal medicine and pharmacology, we excluded medications falling under specific ATC codes. These exclusions encompassed stomatological preparations (A01), blood substitutes and perfusion solutions (B05), topical anti-haemorrhoid (C05A) and anti-varicose drugs (C05B), hormonal contraceptives (G03A), immunoglobulins (J06), vaccines (J07), topical products for joint and muscular pain (M02), anaesthetics (N01), ectoparasiticides (P03), throat preparations (R02), respiratory stimulants and surfactants (R07), medications classified under ‘various’ (V) ATC group, topical dermatological agents, and local ophthalmological and otological agents (except for anti-infective, anti-inflammatory, anti-glaucoma/miotic and mydriatic/cycloplegic agents). These exclusions were based on their predominant use in hospital settings, diagnostic applications, infrequent administration, lack of relevance to the elderly population, minimal interaction risks with other medications and negligible clinical significance. Ultimately, our dataset comprised 2298 drugs categorised under 789 unique ATC-5 codes after applying these exclusion criteria.</p></section><section id="s2-3"><h3 class="pmc_sec_title">Definitions of polypharmacy</h3>
<p>Polypharmacy, broadly defined by the WHO as ‘the administration of an excessive number of drugs’, allows for various interpretations among researchers. Identifying polypharmacy depends on the number of medications taken within a specified time frame. While there is no universal consensus, the threshold of five medications is most frequently used in the literature. Polypharmacy can be further categorised based on the time frame into spontaneous, cumulative or continuous, with chronic polypharmacy defined by the frequency or duration of medication use.<a href="#R16" class="usa-link" aria-describedby="R16"><sup>16</sup></a></p>
<p>Based on the available data, measuring simultaneous polypharmacy was not feasible as it requires information on the duration of each drug’s administration. Additionally, using defined daily doses (DDD) was limited due to the lack of DDD information for many medications in the dataset and the discrepancy between DDD and national prescribing practices, which reduces its accuracy and generalisability. Therefore, we employed a cumulative definition of polypharmacy, considering the total number of different medications administered over a given period. For each individual, we calculated the number of different medications (based on ATC-5) received in 1-month and 6-month intervals. For individuals with multiple prescriptions, polypharmacy was assessed across all intervals generated from each prescription date. Individuals who received five or more different medications in at least one of these intervals during the 3-year study were identified as experiencing cumulative polypharmacy. To evaluate the severity of polypharmacy, we introduced a new definition: consecutive polypharmacy. This was defined as receiving five or more different medications every month or at least once every 2 months within a 6-month period. This definition focuses on prescription frequency rather than chronicity, as the drugs received consecutively could vary from month to month.</p></section><section id="s2-4"><h3 class="pmc_sec_title">Data analysis</h3>
<p>Quantitative variables were summarised using mean and ±SD, while categorical variables were presented as frequencies and percentages with 95% CIs. Prevalence rates of polypharmacy were calculated for various demographic and provincial groups, as well as for different drug classes based on ATC-1, stratified by polypharmacy status, age and sex. The associations between polypharmacy and various demographic factors, as well as consumption of different drug classes, were analysed using univariate and multiple logistic regression, with results reported as crude OR and adjusted ORs (AOR), all with 95% CI. The multiple logistic regression models were adjusted for age, sex, insurance fund and province.</p>
<p>Association rule mining was employed to identify commonly used drugs (based on ATC-4), drug combinations and their relation to polypharmacy. This data mining technique searches for frequent if-then patterns with significance assessed using Support, Confidence and Lift metrics.</p>
<p>Support measures the frequency of an item in the dataset:</p>
<table class="disp-formula p" id="eqnwl1"><tr><td class="formula"><math id="M1" display="block" alttext="Support\left (A\right)=\frac{Number\ of\ records\ containing\ item\ A​}{Total\ number\ of\ records\ }" overflow="linebreak"><mi>S</mi><mi>u</mi><mi>p</mi><mi>p</mi><mi>o</mi><mi>r</mi><mi>t</mi><mo>(</mo><mi>A</mi><mo>)</mo><mo>=</mo><mfrac><mrow><mi>N</mi><mi>u</mi><mi>m</mi><mi>b</mi><mi>e</mi><mi>r</mi><mi></mi><mi>o</mi><mi>f</mi><mi></mi><mi>r</mi><mi>e</mi><mi>c</mi><mi>o</mi><mi>r</mi><mi>d</mi><mi>s</mi><mi></mi><mi>c</mi><mi>o</mi><mi>n</mi><mi>t</mi><mi>a</mi><mi>i</mi><mi>n</mi><mi>i</mi><mi>n</mi><mi>g</mi><mi></mi><mi>i</mi><mi>t</mi><mi>e</mi><mi>m</mi><mi></mi><mi>A</mi><mi>​</mi></mrow><mrow><mi>T</mi><mi>o</mi><mi>t</mi><mi>a</mi><mi>l</mi><mi></mi><mi>n</mi><mi>u</mi><mi>m</mi><mi>b</mi><mi>e</mi><mi>r</mi><mi></mi><mi>o</mi><mi>f</mi><mi></mi><mi>r</mi><mi>e</mi><mi>c</mi><mi>o</mi><mi>r</mi><mi>d</mi><mi>s</mi><mi></mi></mrow></mfrac></math></td></tr></table>
<p>Confidence evaluates the reliability of the association rule, estimating the conditional probability that the consequent is present given the antecedent:</p>
<table class="disp-formula p" id="eqnwl2"><tr><td class="formula"><math id="M2" display="block" alttext="Confidence\left (A\rightarrow B\right)=\ P\left (B|A\right)=\ \frac{Support\left (A\cup B\right)​}{Support\left (A\right)}" overflow="linebreak"><mi>C</mi><mi>o</mi><mi>n</mi><mi>f</mi><mi>i</mi><mi>d</mi><mi>e</mi><mi>n</mi><mi>c</mi><mi>e</mi><mfenced separators="|"><mrow><mi>A</mi><mo>→</mo><mi>B</mi></mrow></mfenced><mo>=</mo><mi></mi><mi>P</mi><mfenced separators="|"><mrow><mi>B</mi></mrow><mrow><mi>A</mi></mrow></mfenced><mo>=</mo><mi></mi><mfrac><mrow><mi>S</mi><mi>u</mi><mi>p</mi><mi>p</mi><mi>o</mi><mi>r</mi><mi>t</mi><mo>(</mo><mi>A</mi><mo>∪</mo><mi>B</mi><mo>)</mo><mi>​</mi></mrow><mrow><mi>S</mi><mi>u</mi><mi>p</mi><mi>p</mi><mi>o</mi><mi>r</mi><mi>t</mi><mo>(</mo><mi>A</mi><mo>)</mo></mrow></mfrac></math></td></tr></table>
<p>Lift assesses the strength of the association relative to independent occurrences:</p>
<table class="disp-formula p" id="eqnwl3"><tr><td class="formula"><math id="M3" display="block" alttext="Lift\left (A\rightarrow B\right)=\frac{Support\left (A\cup B\right)}{Support\left (A\right)\times Support\left (B\right)}" overflow="linebreak"><mi>L</mi><mi>i</mi><mi>f</mi><mi>t</mi><mfenced separators="|"><mrow><mi>A</mi><mo>→</mo><mi>B</mi></mrow></mfenced><mo>=</mo><mfrac><mrow><mi>S</mi><mi>u</mi><mi>p</mi><mi>p</mi><mi>o</mi><mi>r</mi><mi>t</mi><mfenced separators="|"><mrow><mi>A</mi><mo>∪</mo><mi>B</mi></mrow></mfenced></mrow><mrow><mi>S</mi><mi>u</mi><mi>p</mi><mi>p</mi><mi>o</mi><mi>r</mi><mi>t</mi><mfenced separators="|"><mrow><mi>A</mi></mrow></mfenced><mo>×</mo><mi>S</mi><mi>u</mi><mi>p</mi><mi>p</mi><mi>o</mi><mi>r</mi><mi>t</mi><mfenced separators="|"><mrow><mi>B</mi></mrow></mfenced></mrow></mfrac></math></td></tr></table>
<p>We used different levels of the ATC classification system in this study, each chosen to fit the specific needs of our analyses. The ATC-5 level was used to define polypharmacy, as it provides the most detailed subclassification of medications, critical for identifying the use of multiple distinct drugs accurately. For logistic regression analysis, we applied the ATC-1 level, which organises medications into broad therapeutic groups, allowing us to focus on high-level patterns that influence polypharmacy without getting lost in detailed classifications. For association rule mining, we selected the ATC-4 level, which strikes a balance by grouping medications into clinically relevant therapeutic categories—detailed enough to uncover meaningful associations while remaining aggregated enough for the analysis to be manageable and interpretable.</p>
<p>The analysis was conducted using Python programming language V.3.11.4, with Pandas and NumPy libraries for data preparation, Matplotlib for visualisation, SciPy and statsmodels for statistical analysis, and mlxtend for association rule mining.</p></section><section id="s2-5"><h3 class="pmc_sec_title">Patient and public involvement</h3>
<p>Patients and the public were not involved in the design, conduct, reporting or dissemination plans of this research. This study used anonymised secondary data from national health insurance claims, precluding direct engagement with patients or members of the public.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3-1"><h3 class="pmc_sec_title">Prevalence of polypharmacy</h3>
<p>The study assessed polypharmacy prevalence among 1 876 527 elderly individuals who received at least one prescription. Polypharmacy was evaluated using different time windows: cumulative polypharmacy over 6-month and 1-month periods, and consecutive polypharmacy over a 6-month period. The results, along with baseline characteristics of the study population, are presented in <a href="#T1" class="usa-link">table 1</a>.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1. Prevalence of polypharmacy and baseline characteristics.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" valign="bottom" colspan="1">Characteristics</th>
<th valign="bottom" rowspan="1" colspan="1">Total population<br>n=1 876 527</th>
<th valign="bottom" rowspan="1" colspan="1">Cumulative polypharmacy<br>(6-month window)<br>n=1 405 654</th>
<th valign="bottom" rowspan="1" colspan="1">Cumulative polypharmacy<br>(1-month window)<br>n=1 211 378</th>
<th valign="bottom" rowspan="1" colspan="1">Consecutive polypharmacy<br>(6-month window)<br>n=470 873</th>
</tr>
<tr>
<th valign="bottom" rowspan="1" colspan="1">% (95% CI)</th>
<th valign="bottom" rowspan="1" colspan="1">P% (95% CI)</th>
<th valign="bottom" rowspan="1" colspan="1">P% (95% CI)</th>
<th valign="bottom" rowspan="1" colspan="1">P% (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1">Overall</td>
<td align="left" valign="top" rowspan="1" colspan="1">100</td>
<td align="left" valign="top" rowspan="1" colspan="1">74.907<br>(74.845 to 74.969)</td>
<td align="left" valign="top" rowspan="1" colspan="1">64.554<br>(64.486 to 64.623)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.615<br>(7.577 to 7.653)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Sex</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Female</td>
<td align="left" valign="top" rowspan="1" colspan="1">52.897<br>(52.825 to 52.968)</td>
<td align="left" valign="top" rowspan="1" colspan="1">77.825<br>(77.744 to 77.907)</td>
<td align="left" valign="top" rowspan="1" colspan="1">68.359<br>(68.267 to 68.45)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.060<br>(9.003 to 9.116)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Male</td>
<td align="left" valign="top" rowspan="1" colspan="1">47.103<br>(47.032 to 47.175)</td>
<td align="left" valign="top" rowspan="1" colspan="1">71.630<br>(71.536 to 71.724)</td>
<td align="left" valign="top" rowspan="1" colspan="1">60.282<br>(60.18 to 60.384)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.993<br>(5.943 to 6.042)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Age group</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 65–69</td>
<td align="left" valign="top" rowspan="1" colspan="1">37.600<br>(37.531 to 37.669)</td>
<td align="left" valign="top" rowspan="1" colspan="1">74.713<br>(74.611 to 74.814)</td>
<td align="left" valign="top" rowspan="1" colspan="1">63.550<br>(63.438 to 63.662)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.923<br>(6.863 to 6.982)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 70–74</td>
<td align="left" valign="top" rowspan="1" colspan="1">20.553<br>(20.495 to 20.611)</td>
<td align="left" valign="top" rowspan="1" colspan="1">76.583<br>(76.45 to 76.717)</td>
<td align="left" valign="top" rowspan="1" colspan="1">66.415<br>(66.266 to 66.564)</td>
<td align="left" valign="top" rowspan="1" colspan="1">8.546<br>(8.458 to 8.634)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 75–79</td>
<td align="left" valign="top" rowspan="1" colspan="1">17.414<br>(17.36 to 17.468)</td>
<td align="left" valign="top" rowspan="1" colspan="1">77.010<br>(76.865 to 77.154)</td>
<td align="left" valign="top" rowspan="1" colspan="1">67.403<br>(67.243 to 67.564)</td>
<td align="left" valign="top" rowspan="1" colspan="1">8.921<br>(8.824 to 9.019)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 80–84</td>
<td align="left" valign="top" rowspan="1" colspan="1">13.626<br>(13.576 to 13.675)</td>
<td align="left" valign="top" rowspan="1" colspan="1">75.129<br>(74.961 to 75.296)</td>
<td align="left" valign="top" rowspan="1" colspan="1">65.546<br>(65.362 to 65.73)</td>
<td align="left" valign="top" rowspan="1" colspan="1">8.048<br>(7.943 to 8.154)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> ≥85</td>
<td align="left" valign="top" rowspan="1" colspan="1">10.808<br>(10.763 to 10.852)</td>
<td align="left" valign="top" rowspan="1" colspan="1">68.729<br>(68.528 to 68.931)</td>
<td align="left" valign="top" rowspan="1" colspan="1">58.667<br>(58.453 to 58.882)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.602<br>(5.502 to 5.702)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Fund</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Civil Servants</td>
<td align="left" valign="top" rowspan="1" colspan="1">42.017<br>(41.946 to 42.087)</td>
<td align="left" valign="top" rowspan="1" colspan="1">82.952<br>(82.869 to 83.035)</td>
<td align="left" valign="top" rowspan="1" colspan="1">72.569<br>(72.47 to 72.667)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.439<br>(9.374 to 9.504)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Rural</td>
<td align="left" valign="top" rowspan="1" colspan="1">31.344<br>(31.277 to 31.41)</td>
<td align="left" valign="top" rowspan="1" colspan="1">59.055<br>(58.929 to 59.18)</td>
<td align="left" valign="top" rowspan="1" colspan="1">48.305<br>(48.178 to 48.433)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.865<br>(1.831 to 1.9)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Iranian and Universal Health Insurance</td>
<td align="left" valign="top" rowspan="1" colspan="1">16.747<br>(16.694 to 16.801)</td>
<td align="left" valign="top" rowspan="1" colspan="1">77.356<br>(77.21 to 77.503)</td>
<td align="left" valign="top" rowspan="1" colspan="1">65.598<br>(65.432 to 65.765)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.466<br>(5.387 to 5.546)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Other Social Strata</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.739<br>(9.697 to 9.781)</td>
<td align="left" valign="top" rowspan="1" colspan="1">87.317<br>(87.165 to 87.47)</td>
<td align="left" valign="top" rowspan="1" colspan="1">80.789<br>(80.608 to 80.97)</td>
<td align="left" valign="top" rowspan="1" colspan="1">22.066<br>(21.875 to 22.256)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Foreign Citizens</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.154<br>(0.148to 0.159)</td>
<td align="left" valign="top" rowspan="1" colspan="1">55.312<br>(53.497 to 57.128)</td>
<td align="left" valign="top" rowspan="1" colspan="1">44.757<br>(42.941 to 46.573)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T1_FN1"><p>P, prevalence.</p></div></div></section><p>Overall, 74.907% of the population experienced cumulative polypharmacy in a 6-month window, 64.554% in a 1-month window, and 7.615% experienced consecutive polypharmacy in a 6-month window. Females were more likely to experience polypharmacy across all measures compared with males. Age stratification revealed that polypharmacy prevalence increased with age, peaking in the 75–79 age group, while individuals aged 85 and older had the lowest rates of polypharmacy compared with all other age groups. Significant variations were also observed across different insurance funds, with the highest prevalence found in the ‘Other Social Strata’ group, while the ‘Foreign Citizens’ and ‘Rural’ groups had the lowest prevalences.</p></section><section id="s3-2"><h3 class="pmc_sec_title">Drug usage patterns</h3>
<p><a href="#T2" class="usa-link">Table 2</a> summarises drug usage and polypharmacy metrics by polypharmacy status. On average, the total population used 16.10 medications, compared with 3.29 medications for those not exposed to polypharmacy. In polypharmacy groups, usage increased significantly, with consecutive polypharmacy showing the highest average of 41.08 medications. Polypharmacy groups also had more prescriptions, with a mean of 13.44 for cumulative polypharmacy over 6 months and 36.29 for consecutive polypharmacy. The number of prescriptions with five or more drugs was notably higher in polypharmacy groups, especially in consecutive polypharmacy, which averaged 11.79. The mean number of drugs per prescription was similar across consecutive and cumulative polypharmacy groups.</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2. Summary statistics of drug usage and polypharmacy metrics according to polypharmacy status.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" valign="bottom" colspan="1">Variables</th>
<th valign="bottom" rowspan="1" colspan="1">Total population</th>
<th valign="bottom" rowspan="1" colspan="1">Not exposed to polypharmacy</th>
<th valign="bottom" rowspan="1" colspan="1">Cumulative polypharmacy<br>(6-month window)</th>
<th valign="bottom" rowspan="1" colspan="1">Cumulative polypharmacy<br>(1-month window)</th>
<th valign="bottom" rowspan="1" colspan="1">Consecutive polypharmacy<br>(6-month window)</th>
</tr>
<tr>
<th valign="bottom" rowspan="1" colspan="1">Mean (SD)</th>
<th valign="bottom" rowspan="1" colspan="1">Mean (SD)</th>
<th valign="bottom" rowspan="1" colspan="1">Mean (SD)</th>
<th valign="bottom" rowspan="1" colspan="1">Mean (SD)</th>
<th valign="bottom" rowspan="1" colspan="1">Mean (SD)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1">Number of drug classes (ATC-1)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.65 (2.79)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.34 (1.22)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.76 (2.23)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.04 (2.19)</td>
<td align="left" valign="top" rowspan="1" colspan="1">8.95 (1.59)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Number of drugs (ATC-5)</td>
<td align="left" valign="top" rowspan="1" colspan="1">16.10 (13.70)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.29 (1.82)</td>
<td align="left" valign="top" rowspan="1" colspan="1">20.35 (13.33)</td>
<td align="left" valign="top" rowspan="1" colspan="1">22.08 (13.49)</td>
<td align="left" valign="top" rowspan="1" colspan="1">41.08 (16.17)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Number of prescriptions</td>
<td align="left" valign="top" rowspan="1" colspan="1">10.50 (12.20)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.78 (1.38)</td>
<td align="left" valign="top" rowspan="1" colspan="1">13.44 (12.80)</td>
<td align="left" valign="top" rowspan="1" colspan="1">14.69 (13.30)</td>
<td align="left" valign="top" rowspan="1" colspan="1">36.29 (18.33)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Number of prescriptions with ≥5 drugs</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.28 (4.00)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.04 (4.36)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.53 (4.21)</td>
<td align="left" valign="top" rowspan="1" colspan="1">11.79 (6.90)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Number of drugs per prescription</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.20 (1.79)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.11 (0.99)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.25 (1.80)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.31 (1.82)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.71 (2.00)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Number of polypharmacy months</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.49 (4.68)</td>
<td align="left" valign="top" rowspan="1" colspan="1">13.75 (5.60)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Polypharmacy duration by month (without gap)</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.24 (0.68)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.97 (1.59)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Polypharmacy duration by month (1-month gap allowed)</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.90 (2.40)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.82 (5.32)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T2_FN1"><p>ATC, Anatomical Therapeutic Chemical classification.</p></div></div></section><p><a href="#F1" class="usa-link">Figure 1</a> shows the distribution of drug consumption across main anatomical groups (ATC-1) by sex, age group and polypharmacy status. The most commonly used medications belonged to the alimentary tract and metabolism group (<strong>A</strong>). Females generally had higher consumption rates across most drug classes compared with males. However, males had higher consumption rates than females for anti-infectives (<strong>J</strong>), genitourinary drugs (<strong>G</strong>) and antineoplastic and immunomodulating agents (<strong>L</strong>). Consumption patterns remained fairly consistent across age groups, increasing with age until declining after the 80–84 age group. However, consumption of antiparasitic products (<strong>P</strong>) consistently decreased with age. Individuals with consecutive polypharmacy exhibited higher consumption rates across all anatomical groups, while those without polypharmacy had lower consumption rates.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1. Distribution of each drug class consumption by sex (<strong>a</strong>), age group (<strong>b</strong>), and polypharmacy status (<strong>c</strong>). A, alimentary tract and metabolism; ATC, Anatomical Therapeutic Chemical; B, blood and blood-forming organs; C, cardiovascular system; D, dermatologicals; G, genitourinary system and sex hormones; H, systemic hormonal preparations excluding sex hormones and insulins; J, anti-infectives for systemic use; L, antineoplastic and immunomodulating agents; M, musculoskeletal system; n, nervous system; p, antiparasitic products, insecticides and repellents; R, respiratory system; S, sensory organs.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374635_bmjopen-15-8-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5517/12374635/cb902a95de07/bmjopen-15-8-g001.jpg" loading="lazy" height="984" width="737" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="s3-3"><h3 class="pmc_sec_title">Predictors of polypharmacy</h3>
<p>Univariate and multivariate logistic regression analyses are summarised in <a href="#T3" class="usa-link">table 3</a>. Females had significantly higher odds of experiencing polypharmacy compared with males, with 1.484 times higher odds (95% CI: 1.467 to 1.501) for consecutive polypharmacy. Among age groups, individuals aged 75–79 had the highest odds of consecutive polypharmacy compared with the 65–69 group (AOR=1.317, 95% CI: 1.297 to 1.338). However, the trend reversed in individuals aged 85 and older, who had significantly lower odds of polypharmacy (AOR=0.744, 95% CI: 0.728 to 0.761).</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">Table 3. Univariate and multivariate logistic regression analysis of predictors of polypharmacy.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" valign="bottom" colspan="1">Drug class</th>
<th colspan="2" valign="bottom" rowspan="1">Cumulative polypharmacy<br>(6-month window)</th>
<th colspan="2" valign="bottom" rowspan="1">Consecutive polypharmacy<br>(6-month window)</th>
</tr>
<tr>
<th valign="bottom" rowspan="1" colspan="1">Crude OR (95% CI)</th>
<th valign="bottom" rowspan="1" colspan="1">Adjusted OR (95% CI)</th>
<th valign="bottom" rowspan="1" colspan="1">Crude OR (95% CI)</th>
<th valign="bottom" rowspan="1" colspan="1">Adjusted OR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1">Sex</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Male (reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Female</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.390<br>(1.381 to 1.399)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.391<br>(1.382 to 1.401)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.563<br>(1.545 to 1.580)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.484<br>(1.467 to 1.501)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Age group</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 65–69 (reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 70–74</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.107<br>(1.097 to 1.117)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.185<br>(1.174 to 1.197)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.256<br>(1.238 to 1.275)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.290<br>(1.270 to 1.309)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 75–79</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.134<br>(1.123 to 1.145)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.232<br>(1.22 to 1.245)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.317<br>(1.297 to 1.337)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.317<br>(1.297 to 1.338)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 80–84</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.022<br>(1.012 to 1.033)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.118<br>(1.106 to 1.130)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.177<br>(1.157 to 1.197)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.158<br>(1.138 to 1.179)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> ≥85</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.744<br>(0.736 to 0.752)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.749<br>(0.741 to 0.758)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.798<br>(0.781 to 0.815)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.744<br>(0.728 to 0.761)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Fund</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Civil Servants (reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Rural</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.296<br>(0.294 to 0.299)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.244<br>(0.242 to 0.246)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.183<br>(0.179 to 0.187)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.156<br>(0.153 to 0.160)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Iranian and Universal Health Insurance</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.702<br>(0.695 to 0.709)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.731<br>(0.724 to 0.739)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.557<br>(0.547 to 0.566)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.601<br>(0.590 to 0.611)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Other Social Strata</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.415<br>(1.394 to 1.436)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.277<br>(1.258 to 1.297)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.727<br>(2.691 to 2.764)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.448<br>(2.415 to 2.482)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Foreign Citizens</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.254<br>(0.236 to 0.274)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.231<br>(0.214 to 0.249)</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
<td align="left" valign="top" rowspan="1" colspan="1">---</td>
</tr>
<tr><td valign="top" colspan="5" rowspan="1">Main anatomical groups (ATC-1)</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> A (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">11.308<br>(11.221 to 11.396)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.320<br>(9.246 to 9.395)</td>
<td align="left" valign="top" rowspan="1" colspan="1">46.471<br>(43.778 to 49.329)</td>
<td align="left" valign="top" rowspan="1" colspan="1">29.711<br>(27.985 to 31.544)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> B (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">10.475<br>(10.382 to 10.569)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.590<br>(9.502 to 9.679)</td>
<td align="left" valign="top" rowspan="1" colspan="1">11.745<br>(11.528 to 11.965)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.272<br>(9.098 to 9.448)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> C (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">12.322<br>(12.227 to 12.418)</td>
<td align="left" valign="top" rowspan="1" colspan="1">10.502<br>(10.419 to 10.587)</td>
<td align="left" valign="top" rowspan="1" colspan="1">32.427<br>(31.118 to 33.792)</td>
<td align="left" valign="top" rowspan="1" colspan="1">22.597<br>(21.681 to 23.553)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> D (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.825<br>(2.576 to 3.097)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.192<br>(1.995 to 2.409)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.620<br>(2.432 to 2.823)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.054<br>(1.9 to 2.221)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> G (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.841<br>(4.778 to 4.905)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.191<br>(4.135 to 4.248)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.646<br>(3.605 to 3.687)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.901<br>(2.867 to 2.936)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> H (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.257<br>(7.2 to 7.314)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.111<br>(6.061 to 6.161)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.972<br>(4.9 to 5.044)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.514<br>(3.462 to 3.566)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> J (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.964<br>(6.914 to 7.015)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.787<br>(5.743 to 5.831)</td>
<td align="left" valign="top" rowspan="1" colspan="1">8.422<br>(8.239 to 8.608)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.705<br>(5.579 to 5.834)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> L (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.652<br>(4.523 to 4.785)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.603<br>(4.473 to 4.737)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.005<br>(2.948 to 3.063)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.022<br>(2.961 to 3.084)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> M (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.779<br>(6.727 to 6.831)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.468<br>(5.424 to 5.512)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.625<br>(6.519 to 6.732)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.460<br>(4.387 to 4.534)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> N (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.903<br>(9.829 to 9.978)</td>
<td align="left" valign="top" rowspan="1" colspan="1">8.033<br>(7.971 to 8.096)</td>
<td align="left" valign="top" rowspan="1" colspan="1">17.764<br>(17.215 to 18.33)</td>
<td align="left" valign="top" rowspan="1" colspan="1">11.463<br>(11.106 to 11.832)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> P (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.963<br>(5.88 to 6.048)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.772<br>(4.705 to 4.841)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.777<br>(3.735 to 3.819)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.846<br>(2.813 to 2.88)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> R (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.175<br>(9.098 to 9.252)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.406<br>(7.343 to 7.470)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.829<br>(7.7 to 7.961)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.214<br>(5.125 to 5.304)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> S (non-users as reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.564<br>(2.544 to 2.585)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.235<br>(2.216 to 2.253)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.258<br>(3.222 to 3.295)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.572<br>(2.542 to 2.601)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T3_FN3"><p>Adjustment variables: age group, sex, fund and province.</p></div>
<div class="fn" id="T3_FN1"><p>A, alimentary tract and metabolism; ATC, Anatomical Therapeutic Chemical classification; B, blood and blood-forming organs; C, cardiovascular system; D, dermatologicals; G, genitourinary system and sex hormones; H, systemic hormonal preparations excluding sex hormones and insulins; J, anti-infectives for systemic use; L, antineoplastic and immunomodulating agents; M, musculoskeletal system; N, nervous system; P, antiparasitic products, insecticides and repellents; R, respiratory system; S, sensory organs.</p></div>
</div></section><p>Insurance status also influenced polypharmacy risk. Compared with the Civil Servants fund, those in the Rural Fund and Iranian and Universal Health Insurance had lower odds of polypharmacy, while individuals in the Other Social Strata fund had a much higher risk. Foreign citizens had the lowest odds of cumulative polypharmacy (AOR=0.231, 95% CI: 0.214 to 0.249), but no cases of consecutive polypharmacy were observed in this group.</p>
<p>Logistic regression analysis revealed that having a prescription history of medications from certain main anatomical groups (ATC-1) was strongly associated with an increased likelihood of polypharmacy. Specifically, those with a prescription history from the alimentary tract and metabolism group (class A) were 29.711 times more likely (95% CI: 27.985 to 31.544) to experience consecutive polypharmacy compared with those who had never been prescribed medications from this class. Following class A, class C (cardiovascular system), class N (nervous system) and class B (blood and blood-forming organs) also showed strong associations, with AORs of 22.597, 11.463 and 9.272 for consecutive polypharmacy, respectively. For all drug classes, the AORs were lower than the crude ORs. In general, AORs for consecutive polypharmacy were similar to or lower than those for cumulative polypharmacy across most drug classes. However, exceptions were seen in classes A, C and N, where the ORs for consecutive polypharmacy were higher than those for cumulative polypharmacy.</p></section><section id="s3-4"><h3 class="pmc_sec_title">Regional variations</h3>
<p>The analysis revealed significant regional variation in polypharmacy across provinces (<a href="#F2" class="usa-link">figure 2</a>). Prevalence rates ranged from 60.69% (Hormozgan) to 80.85% (Isfahan) for cumulative polypharmacy and 2.76% (Hormozgan) to 13.60% (Ilam) for consecutive polypharmacy. Multivariate logistic regression analysis showed that Fars had the highest odds for cumulative polypharmacy (AOR=2.36), while Chaharmahal and Bakhtiari had the highest odds for consecutive polypharmacy (AOR=4.21), both in comparison to Tehran.</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Polypharmacy prevalence and ORs by province.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374635_bmjopen-15-8-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5517/12374635/1f078a67e568/bmjopen-15-8-g002.jpg" loading="lazy" height="970" width="770" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="s3-5"><h3 class="pmc_sec_title">Commonly used medications and their association with polypharmacy</h3>
<p><a href="#T4" class="usa-link">Table 4</a> presents the most commonly used medications by pharmacological subgroup (ATC-4) overall and by polypharmacy status. Systemic glucocorticoids were the most commonly used overall (50.02%), followed by HMG-CoA reductase inhibitors (42.73%) and platelet aggregation inhibitors excluding heparin (41.92%). HMG-CoA reductase inhibitors were the most prevalent in consecutive polypharmacy (83.54%), followed by platelet aggregation inhibitors (82.84%), while glucocorticoids were the most common in non-polypharmacy (18.26%) and cumulative polypharmacy (60.66%) groups. As shown in <a href="#T5" class="usa-link">table 5</a>, platelet aggregation inhibitors had the strongest association with organic nitrates (lift=2.01) and were coprescribed in 20.78% of the population. Additionally, platelet aggregation inhibitors and HMG-CoA reductase inhibitors were strongly associated with each other, as well as with beta-blockers and angiotensin-II receptor blockers (ARBs). Glucocorticoids were also associated with acetic acid derivatives, third-generation cephalosporins and anilides.</p>
<section class="tw xbox font-sm" id="T4"><h4 class="obj_head">Table 4. The most commonly used medications in total and in different polypharmacy status.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="2" valign="bottom" rowspan="1">Total</th>
<th colspan="2" valign="bottom" rowspan="1">Non-polypharmacy</th>
<th colspan="2" valign="bottom" rowspan="1">Cumulative polypharmacy</th>
<th colspan="2" valign="bottom" rowspan="1">Consecutive polypharmacy</th>
</tr>
<tr>
<th align="left" valign="top" rowspan="1" colspan="1">Pharmacological subgroup (ATC-4)</th>
<th align="left" valign="top" rowspan="1" colspan="1">Proportion<br>(%)</th>
<th align="left" valign="top" rowspan="1" colspan="1">Pharmacological subgroup (ATC-4)</th>
<th align="left" valign="top" rowspan="1" colspan="1">Proportion<br>(%)</th>
<th align="left" valign="top" rowspan="1" colspan="1">Pharmacological subgroup (ATC-4)</th>
<th align="left" valign="top" rowspan="1" colspan="1">Proportion<br>(%)</th>
<th align="left" valign="top" rowspan="1" colspan="1">Pharmacological subgroup (ATC-4)</th>
<th align="left" valign="top" rowspan="1" colspan="1">Proportion<br>(%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Glucocorticoids<br>(H02AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">50.02</td>
<td align="left" valign="top" rowspan="1" colspan="1">Glucocorticoids<br>(H02AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">18.26</td>
<td align="left" valign="top" rowspan="1" colspan="1">Glucocorticoids<br>(H02AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">60.66</td>
<td align="left" valign="top" rowspan="1" colspan="1">HMG-CoA reductase inhibitors<br>(C10AA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">83.54</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HMG-CoA reductase inhibitors<br>(C10AA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">42.73</td>
<td align="left" valign="top" rowspan="1" colspan="1">Acetic acid derivatives and related substances<br>(M01AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">11.06</td>
<td align="left" valign="top" rowspan="1" colspan="1">HMG-CoA reductase Inhibitors<br>(C10AA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">53.94</td>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin<br>(B01AC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">82.84</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin<br>(B01AC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">41.92</td>
<td align="left" valign="top" rowspan="1" colspan="1">Vitamin D and analogues<br>(A11CC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.97</td>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin<br>(B01AC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">52.90</td>
<td align="left" valign="top" rowspan="1" colspan="1">Glucocorticoids<br>(H02AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">79.62</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Acetic acid derivatives and related substances<br>(M01AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">36.83</td>
<td align="left" valign="top" rowspan="1" colspan="1">Fluoroquinolones<br>(J01MA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.75</td>
<td align="left" valign="top" rowspan="1" colspan="1">Angiotensin-II receptor blockers (ARBs), plain<br>(C09CA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">45.97</td>
<td align="left" valign="top" rowspan="1" colspan="1">Angiotensin-II receptor blockers (ARBs), plain<br>(C09CA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">76.22</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Angiotensin-II receptor blockers (ARBs), plain<br>(C09CA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">36.31</td>
<td align="left" valign="top" rowspan="1" colspan="1">Antibiotics, ophthalmological<br>(S01AA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.29</td>
<td align="left" valign="top" rowspan="1" colspan="1">Acetic acid derivatives and related substances<br>(M01AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">45.46</td>
<td align="left" valign="top" rowspan="1" colspan="1">Anilides<br>(N02BE)</td>
<td align="left" valign="top" rowspan="1" colspan="1">74.68</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Vitamin D And analogues<br>(A11CC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">35.80</td>
<td align="left" valign="top" rowspan="1" colspan="1">HMG-CoA reductase inhibitors<br>(C10AA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.29</td>
<td align="left" valign="top" rowspan="1" colspan="1">Anilides<br>(N02BE)</td>
<td align="left" valign="top" rowspan="1" colspan="1">44.98</td>
<td align="left" valign="top" rowspan="1" colspan="1">H2-receptor antagonists<br>(A02BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">72.53</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Anilides<br>(N02BE)</td>
<td align="left" valign="top" rowspan="1" colspan="1">35.67</td>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin<br>(B01AC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9.14</td>
<td align="left" valign="top" rowspan="1" colspan="1">Vitamin D and analogues<br>(A11CC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">44.45</td>
<td align="left" valign="top" rowspan="1" colspan="1">Acetic acid derivatives and related substances<br>(M01AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">71.50</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">H2-receptor antagonists<br>(A02BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">32.78</td>
<td align="left" valign="top" rowspan="1" colspan="1">Corticosteroids, ophthalmological<br>(S03BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">8.79</td>
<td align="left" valign="top" rowspan="1" colspan="1">H2-Receptor antagonists<br>(A02BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">41.43</td>
<td align="left" valign="top" rowspan="1" colspan="1">Vitamin D And analogues<br>(A11CC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">70.49</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Third-generation cephalosporins<br>(J01DD)</td>
<td align="left" valign="top" rowspan="1" colspan="1">32.10</td>
<td align="left" valign="top" rowspan="1" colspan="1">Third-generation cephalosporins<br>(J01DD)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.96</td>
<td align="left" valign="top" rowspan="1" colspan="1">Third-generation cephalosporins<br>(J01DD)</td>
<td align="left" valign="top" rowspan="1" colspan="1">40.18</td>
<td align="left" valign="top" rowspan="1" colspan="1">Third-generation cephalosporins<br>(J01DD)</td>
<td align="left" valign="top" rowspan="1" colspan="1">67.61</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Beta blocking agents, selective<br>(C07AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">30.17</td>
<td align="left" valign="top" rowspan="1" colspan="1">Anilides<br>(N02BE)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.89</td>
<td align="left" valign="top" rowspan="1" colspan="1">Beta blocking agents, selective<br>(C07AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">38.38</td>
<td align="left" valign="top" rowspan="1" colspan="1">Beta-blocking agents, selective<br>(C07AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">65.31</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Fluoroquinolones<br>(J01MA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">27.48</td>
<td align="left" valign="top" rowspan="1" colspan="1">Angiotensin-II receptor blockers (ARBs), plain<br>(C09CA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.46</td>
<td align="left" valign="top" rowspan="1" colspan="1">Fluoroquinolones<br>(J01MA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">33.42</td>
<td align="left" valign="top" rowspan="1" colspan="1">Proton pump inhibitors<br>(A02BC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">62.57</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Proton pump inhibitors<br>(A02BC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">26.24</td>
<td align="left" valign="top" rowspan="1" colspan="1">H2-receptor antagonists<br>(A02BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.95</td>
<td align="left" valign="top" rowspan="1" colspan="1">Proton pump inhibitors<br>(A02BC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">33.30</td>
<td align="left" valign="top" rowspan="1" colspan="1">Benzodiazepine derivatives<br>(N05BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">61.34</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Benzodiazepine derivatives<br>(N05BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">26.05</td>
<td align="left" valign="top" rowspan="1" colspan="1">Corticosteroids, plain, ophthalmological<br>(S01BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.38</td>
<td align="left" valign="top" rowspan="1" colspan="1">Benzodiazepine derivatives<br>(N05BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">33.07</td>
<td align="left" valign="top" rowspan="1" colspan="1">Organic nitrates<br>(C01DA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">61.19</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Macrolides<br>(J01FA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">25.15</td>
<td align="left" valign="top" rowspan="1" colspan="1">First-generation cephalosporins<br>(J01DB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.80</td>
<td align="left" valign="top" rowspan="1" colspan="1">Macrolides<br>(J01FA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">31.90</td>
<td align="left" valign="top" rowspan="1" colspan="1">Macrolides<br>(J01FA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">55.84</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Organic nitrates<br>(C01DA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">24.70</td>
<td align="left" valign="top" rowspan="1" colspan="1">Beta-blocking agents, selective<br>(C07AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.66</td>
<td align="left" valign="top" rowspan="1" colspan="1">Organic nitrates<br>(C01DA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">31.85</td>
<td align="left" valign="top" rowspan="1" colspan="1">Fluoroquinolones<br>(J01MA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">55.43</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T4_FN1"><p>ATC, Anatomical Therapeutic Chemical classification.</p></div></div></section><section class="tw xbox font-sm" id="T5"><h4 class="obj_head">Table 5. The most common medications taken together.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="bottom" rowspan="1" colspan="1">Combination (ATC-4)</th>
<th valign="bottom" rowspan="1" colspan="1">Support (%)</th>
<th valign="bottom" rowspan="1" colspan="1">Lift</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin (B01AC) + Organic nitrates (C01DA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">20.78</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.01</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin (B01AC) + Beta-blocking agents, selective (C07AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">22.21</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.76</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin (B01AC) + HMG-CoA reductase inhibitors (C10AA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">31.39</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.75</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HMG-CoA reductase inhibitors (C10AA) + Beta-blocking agents, selective (C07AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">21.68</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.68</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin (B01AC) + Angiotensin-II receptor blockers (ARBs), plain (C09CA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">25.09</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.65</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HMG-CoA reductase inhibitors (C10AA) + Angiotensin-II receptor blockers (ARBs), plain (C09CA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">25.02</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.61</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Vitamin D and analogues (A11CC) + Acetic acid derivatives and related substances (M01AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">20.77</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.58</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Acetic acid derivatives and related substances (M01AB) + Glucocorticoids (H02AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">27.33</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.48</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Third-generation cephalosporins (J01DD) + Glucocorticoids (H02AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">22.77</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.42</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Anilides (N02BE) + Glucocorticoids (H02AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">25.13</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.41</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T5_FN1"><p>ATC, Anatomical Therapeutic Chemical classification.</p></div></div></section><p>The simultaneous presence of glucocorticoids and HMG-CoA reductase inhibitors in an individual’s prescription history showed the most prominent relationship with consecutive polypharmacy (confidence=20.6%, lift=2.71). Additionally, simultaneous consumption of ARBs with HMG-CoA reductase inhibitors (confidence=20.4%, lift=2.68) and platelet aggregation inhibitors (confidence=20.2%, lift=2.65) significantly increased the possibility of consecutive polypharmacy. Other medications, such as H2-receptor antagonists, third-generation cephalosporins, anilides, vitamin D and acetic acid derivatives, showed notable but less frequent associations with consecutive polypharmacy (<a href="#T6" class="usa-link">table 6</a>).</p>
<section class="tw xbox font-sm" id="T6"><h4 class="obj_head">Table 6. Association rules of medications or their combinations and consecutive polypharmacy.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="bottom" rowspan="1" colspan="1">Antecedent (ATC-4)</th>
<th valign="bottom" rowspan="1" colspan="1">Support (%)</th>
<th valign="bottom" rowspan="1" colspan="1">Confidence (%)</th>
<th valign="bottom" rowspan="1" colspan="1">Lift</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Glucocorticoids (H02AB) + HMG-CoA reductase inhibitors (C10AA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.02</td>
<td align="left" valign="top" rowspan="1" colspan="1">20.60</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.71</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Angiotensin-II receptor blockers (ARBs), plain (C09CA) + HMG-CoA reductase inhibitors</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.10</td>
<td align="left" valign="top" rowspan="1" colspan="1">20.40</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.68</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Angiotensin-II receptor blockers (ARBs), plain (C09CA) + Platelet aggregation inhibitors excl. heparin (B01AC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.07</td>
<td align="left" valign="top" rowspan="1" colspan="1">20.20</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.65</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HMG-CoA reductase inhibitors (C10AA) + Platelet aggregation inhibitors excl. heparin (B01AC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.61</td>
<td align="left" valign="top" rowspan="1" colspan="1">17.88</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.35</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">H2-receptor antagonists (A02BA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.52</td>
<td align="left" valign="top" rowspan="1" colspan="1">16.85</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.21</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Third-generation cephalosporins (J01DD)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.15</td>
<td align="left" valign="top" rowspan="1" colspan="1">16.04</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.11</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Angiotensin-II receptor blockers (ARBs), plain (C09CA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.80</td>
<td align="left" valign="top" rowspan="1" colspan="1">15.99</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.10</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Anilides (N02BE)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.69</td>
<td align="left" valign="top" rowspan="1" colspan="1">15.94</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.09</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Platelet aggregation inhibitors excl. heparin (B01AC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.31</td>
<td align="left" valign="top" rowspan="1" colspan="1">15.05</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.98</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Vitamin D and analogues (A11CC)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.37</td>
<td align="left" valign="top" rowspan="1" colspan="1">15.00</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.97</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HMG-CoA reductase inhibitors (C10AA)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.36</td>
<td align="left" valign="top" rowspan="1" colspan="1">14.89</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.95</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Acetic acid derivatives and related substances (M01AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.44</td>
<td align="left" valign="top" rowspan="1" colspan="1">14.78</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.94</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Glucocorticoids (H02AB)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.06</td>
<td align="left" valign="top" rowspan="1" colspan="1">12.12</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.59</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T6_FN1"><p>ATC, Anatomical Therapeutic Chemical classification.</p></div></div></section></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>In this study, we investigated the prevalence and characteristics of polypharmacy among the elderly population in Iran over a 3-year period using IHIO claims data. Our findings revealed a high prevalence of polypharmacy among older adults, with approximately 75% of the study population being prescribed more than five different medications within a 6-month period. Additionally, one-third of these individuals (7.6% of the total population) experienced sustained exposure to polypharmacy, a measure we defined as consecutive polypharmacy. The analysis revealed significant demographic patterns, with females more likely to experience polypharmacy across all measures, and the highest prevalence observed in the 75–79 age group. There were also substantial variations in polypharmacy prevalence across different insurance funds and provinces, indicating the influence of socioeconomic and regional factors.</p>
<p>When comparing our findings to similar studies conducted in other countries, the prevalence of polypharmacy among the elderly in Iran is notably high but consistent with global patterns. In the same region, a retrospective analysis in Qatar in 2017 found a polypharmacy prevalence of 75.5% among older adults using Electronic Medical Records from primary healthcare centres over a 6-month period, closely matching our results.<a href="#R17" class="usa-link" aria-describedby="R17"><sup>17</sup></a> Similarly, a 2016 study in Saudi Arabia found that 66.3% of those aged 60 and above were on five or more medications based on a 6-month study of outpatient electronic health records.<a href="#R18" class="usa-link" aria-describedby="R18"><sup>18</sup></a> In East Asia, the highest prevalence was observed in Korea, where 86.4% of the elderly were affected, according to data from the Korea Health Insurance Review and Assessment Service from 2010 and 2011.<a href="#R19" class="usa-link" aria-describedby="R19"><sup>19</sup></a> In Tokyo, Japan, 63.5% of outpatients aged 75 and older were prescribed five or more drug types during a 6-month period in 2014.<a href="#R20" class="usa-link" aria-describedby="R20"><sup>20</sup></a> In contrast, a study in Switzerland using 2016 health insurance claims data found that 50.4% of the elderly experienced polypharmacy during a 3-month period.<a href="#R21" class="usa-link" aria-describedby="R21"><sup>21</sup></a> These comparisons highlight that the high prevalence of polypharmacy in Iran is part of a broader global trend, with variations likely due to differences in healthcare systems, prescribing practices and population health profiles.</p>
<p>Consistent with other studies, polypharmacy prevalence was significantly higher among females in our study,<a href="#R17" class="usa-link" aria-describedby="R17"><sup>17 18 21 22</sup></a> though some studies have reported higher rates in males.<a href="#R19" class="usa-link" aria-describedby="R19"><sup>19 20</sup></a> These inconsistencies may stem from differences in physicians’ prescribing attitude towards males and females,<a href="#R23" class="usa-link" aria-describedby="R23"><sup>23 24</sup></a> as well as variations in health-seeking behaviours between sexes.<a href="#R25" class="usa-link" aria-describedby="R25"><sup>25</sup></a> Polypharmacy is also strongly linked to non-communicable diseases and the number of chronic conditions.<a href="#R10" class="usa-link" aria-describedby="R10"><sup>10 17</sup></a> An Iranian study using latent class analysis found females more likely to fall into cardiovascular-metabolic and cognitive-metabolic multimorbidity classes, both associated with polypharmacy.<a href="#R26" class="usa-link" aria-describedby="R26"><sup>26</sup></a> Thus, the higher polypharmacy prevalence in females may be partly due to their greater burden of certain multimorbidities.</p>
<p>Our study found that individuals aged 75–79 had the highest odds of polypharmacy compared with the 65–69 age group, while those aged 85 and older showed significantly lower odds. This pattern aligns with other research showing an initial increase in polypharmacy with age, that can be due to the accumulation of chronic conditions and multimorbidity, followed by a decrease in the very elderly.<a href="#R19" class="usa-link" aria-describedby="R19"><sup>19 21</sup></a> An Italian study on prescription patterns found that medication use significantly declined after age 90, with reductions most notable for chronic disease treatments (eg, antihypertensives) and less so for acute condition medications (eg, antibiotics and glucocorticoids).<a href="#R27" class="usa-link" aria-describedby="R27"><sup>27</sup></a> Our findings similarly indicated a decrease in overall medication use among the oldest age group, with a more pronounced reduction in classes like cardiovascular (class C) and nervous system (class N) drugs compared with anti-infectives (class J). These findings may reflect a more cautious medical approach in the oldest age group due to changes in the risk–benefit profile of treatments. Chronic disease management may also become less prioritised given limited life expectancy, with medications for acute conditions or symptoms taking precedence over preventive therapies. Additionally, a healthy survivor effect may explain why only the fittest individuals, requiring fewer medications, live past 85. Lastly, reduced access to care and potential age-related discrimination may also contribute to lower polypharmacy in the very old.<a href="#R28" class="usa-link" aria-describedby="R28"><sup>28</sup></a></p>
<p>When examining the impact of health insurance status on polypharmacy, our study found that individuals in the Rural and Foreign Citizens Funds had significantly lower odds of polypharmacy compared with those in the Civil Servants Fund. This difference may stem from reduced access to healthcare services, fewer medical consultations and more conservative healthcare-seeking behaviours in rural areas.<a href="#R29" class="usa-link" aria-describedby="R29"><sup>29</sup></a> For foreign citizens, factors such as cultural preferences, legal barriers and cost concerns are likely to contribute to their lower polypharmacy rates. More targeted studies are needed to explore the underlying causes of these disparities and to develop strategies to address potential gaps in healthcare delivery.</p>
<p>The most commonly prescribed drug classes associated with consecutive polypharmacy in our study included those related to the alimentary tract and metabolism, cardiovascular system, nervous system and blood and blood-forming organs. Specifically, vitamin D and analogues, H2-receptor antagonists and proton pump inhibitors were frequently prescribed for alimentary tract and metabolism issues, while HMG-CoA reductase inhibitors, ARBs, beta-blockers and organic nitrates dominated cardiovascular prescriptions. In the nervous system category, anilides and benzodiazepines were prominent, and platelet aggregation inhibitors were common among drugs acting on blood and blood-forming organs. This pattern of medication use aligns with the chronic conditions prevalent in the elderly population.<a href="#R30" class="usa-link" aria-describedby="R30"><sup>30</sup></a> Supporting our findings, a study in Tehran found that cardiovascular drugs accounted for 20.8% of all prescriptions among elderly patients, with a significant portion also receiving drugs for diabetes and nutritional supplements.<a href="#R31" class="usa-link" aria-describedby="R31"><sup>31</sup></a> Additionally, the Pars Cohort Study in Iran highlighted that cardiovascular drugs, drugs acting on blood and blood-forming organs, and alimentary tract and metabolism drugs were the most frequently used among patients with cardiovascular diseases.<a href="#R32" class="usa-link" aria-describedby="R32"><sup>32</sup></a> Consistently, association rule mining analysis in our study showed that HMG-CoA reductase inhibitors, ARBs and platelet aggregation inhibitors were most commonly used together in patients with polypharmacy.</p>
<p>Systemic glucocorticoids were the most prevalent pharmacological subgroup (ATC-4) in our study, with half of the elderly population having used them during the study period. This high prevalence is consistent with other studies that highlight the widespread use of glucocorticoids, particularly dexamethasone, among general physicians.<a href="#R11" class="usa-link" aria-describedby="R11"><sup>11</sup></a> The popularity of glucocorticoids can be attributed to their rapid alleviation of disease symptoms, making them a favoured choice for both doctors and patients despite their well-documented side effects, including hypertension, weight gain, increased blood sugar, osteoporosis, mood swings, cardiovascular diseases, increased risk of infections and delay in diagnosis and treatment of diseases.<a href="#R33" class="usa-link" aria-describedby="R33"><sup>33</sup></a> However, the frequent use of glucocorticoids is concerning, as overprescription exacerbates health risks for patients and increases healthcare costs by prolonging treatment and leading to additional complications. The high rate of glucocorticoid prescriptions may reflect a combination of factors, including gaps in physician knowledge, strong patient demand, limited access to alternative treatments and weak regulatory oversight.<a href="#R34" class="usa-link" aria-describedby="R34"><sup>34</sup></a> Addressing these issues by enhancing physician education and improving regulatory frameworks is crucial to curbing the overuse of glucocorticoids and reducing their associated risks.</p>
<p>While prescribing multiple medications can be clinically justified and isn't inherently inappropriate, it does increase the risk of adverse drug events and healthcare costs. Polypharmacy also raises the concern of overtreatment, where medications offer little clinical benefit for the patient’s remaining lifespan or where the risks outweigh the potential benefits of additional treatments.<a href="#R35" class="usa-link" aria-describedby="R35"><sup>35</sup></a> Our study sheds light on medication use patterns and polypharmacy, providing valuable insights for healthcare providers, emphasising the need for targeted interventions to manage and optimise medication use among the elderly. Implementing regular medication reviews, deprescribing strategies and, when appropriate, represcribing—the addition of beneficial medications that are often omitted—could help minimise the risks associated with both overtreatment and undertreatment.<a href="#R36" class="usa-link" aria-describedby="R36">36</a>,<a href="#R39" class="usa-link" aria-describedby="R39">39</a> In this context, structured tools such as the Screening Tool to Alert to Right Treatment/Screening Tool of Older Persons’ Prescriptions (START/STOPP) criteria and the Fit fOR The Aged (FORTA) list, which have demonstrated clinical benefits in randomised trials, offer promising patient-centred approaches. Unlike purely drug-oriented listing tools like the Beers criteria, these instruments consider both potentially inappropriate medications and potentially omitted medications, supporting a more holistic medication optimisation strategy known as represcribing.<a href="#R39" class="usa-link" aria-describedby="R39"><sup>39</sup></a> Further research should focus on exploring the long-term impacts of polypharmacy on patient outcomes and evaluating the effectiveness of interventions designed to reduce inappropriate prescribing.</p>
<p>This study has several strengths, including the use of a large, nationwide dataset that allows for analysis with sufficient statistical power and provides a comprehensive overview of polypharmacy among the elderly in Iran. Furthermore, we employed association rule mining to investigate patterns of polypharmacy and identify drugs commonly used together, which is a novel method in this context and adds depth to our analysis. The focus on consecutive polypharmacy offers valuable insights into the persistence of polypharmacy, a critical factor in understanding its potential risks.</p>
<p>However, there are several limitations to consider. The use of claims data, while extensive, lacks detailed clinical information such as the rationale for prescriptions and patient adherence, which limits our ability to fully assess the appropriateness of polypharmacy. Additionally, our analysis did not account for non-prescription medications, such as over-the-counter drugs and herbal supplements, which may lead to an underestimation of polypharmacy prevalence. Another significant limitation is the lack of a standardised definition for polypharmacy across different studies. This variation in definitions makes it challenging to directly compare our findings with those from other research, as the criteria for what constitutes polypharmacy can differ widely. Finally, while our study is representative of the elderly population in Iran, the findings may not be fully generalisable to the entire population of interest, as our data were limited to elderly individuals covered by the IHIO who received at least one medication during the study period.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusions</h2>
<p>This study provides a comprehensive analysis of polypharmacy prevalence and patterns among the elderly population in Iran using health insurance claims data. The findings highlight the widespread occurrence of polypharmacy, with nearly three-quarters of the elderly experiencing cumulative polypharmacy and a smaller yet significant portion affected by consecutive polypharmacy. Polypharmacy was more common among females and those aged 75–79, with significant variations across insurance funds and provinces. The study underscores the significant role of specific drug classes, such as those related to the alimentary tract, cardiovascular system and nervous system, in driving polypharmacy. Overall, this study contributes to a better understanding of polypharmacy in the Iranian elderly population, providing a foundation for future research and policy initiatives aimed at improving medication safety and health outcomes in this vulnerable group.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors would like to thank everyone who contributed to this study, including our colleagues and mentors at Tehran University of Medical Sciences. We are especially grateful to the Non-Communicable Diseases Research Center of the Endocrinology and Metabolism Population Sciences Institute at Tehran University of Medical Sciences for providing essential resources and facilities. We also thank the Iran Health Insurance Organization for supplying the valuable data that made this study possible.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn9"><p><strong>Funding:</strong> This work was supported by the Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran (Grant IDs 1402-2-221-66993).</p></div>
<div class="fn p" id="fn10"><p>Prepublication history for this paper is available online. To view these files, please visit the journal online (<a href="https://doi.org/10.1136/bmjopen-2024-097863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1136/bmjopen-2024-097863</a>).</p></div>
<div class="fn p" id="fn11"><p><strong>Data availability free text:</strong> Data are not publicly available due to patient privacy restrictions. Anonymised data may be made available on reasonable request and with permission from the Iran Health Insurance Organization (IHIO) via its official website.</p></div>
<div class="fn p" id="fn12"><p><strong>Patient consent for publication:</strong> Not applicable.</p></div>
<div class="fn p" id="fn13"><p><strong>Ethics approval:</strong> Access to fully anonymised data was granted to the Non-Communicable Diseases Research Center (NCDRC) of Tehran University of Medical Sciences, Tehran, Iran, where the analysis was conducted. This study adhered to the principles outlined in the Declaration of Helsinki and received approval from the Ethical Committee of the Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran (IR.TUMS.EMRI.REC.1402.063).</p></div>
<div class="fn p" id="fn14"><p><strong>Provenance and peer review:</strong> Not commissioned; externally peer reviewed.</p></div>
<div class="fn p" id="fn15"><p><strong>Patient and public involvement:</strong> Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.</p></div>
</div></section><section id="sec24"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>Data are available on reasonable request.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>World Health Organization  . Geneva: World Health Organization; 2019. Medication safety in polypharmacy: technical report. Contract No.: WHO/UHC/SDS/2019.11.</cite> [<a href="https://scholar.google.com/scholar_lookup?World%20Health%20Organization%20.%20Geneva:%20World%20Health%20Organization;%202019.%20Medication%20safety%20in%20polypharmacy:%20technical%20report.%20Contract%20No.:%20WHO/UHC/SDS/2019.11." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Delara M, Murray L, Jafari B, et al.  Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22:601.  doi: 10.1186/s12877-022-03279-x.</cite> [<a href="https://doi.org/10.1186/s12877-022-03279-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9297624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35854209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Geriatr&amp;title=Prevalence%20and%20factors%20associated%20with%20polypharmacy:%20a%20systematic%20review%20and%20meta-analysis&amp;author=M%20Delara&amp;author=L%20Murray&amp;author=B%20Jafari&amp;volume=22&amp;publication_year=2022&amp;pages=601&amp;pmid=35854209&amp;doi=10.1186/s12877-022-03279-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12:443–52. doi: 10.1007/s41999-021-00479-3.</cite> [<a href="https://doi.org/10.1007/s41999-021-00479-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8149355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33694123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Geriatr%20Med&amp;title=Polypharmacy%20in%20older%20adults:%20a%20narrative%20review%20of%20definitions,%20epidemiology%20and%20consequences&amp;author=F%20Pazan&amp;author=M%20Wehling&amp;volume=12&amp;publication_year=2021&amp;pages=443-52&amp;pmid=33694123&amp;doi=10.1007/s41999-021-00479-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Hsu H-F, Chen K-M, Belcastro F, et al.  Polypharmacy and pattern of medication use in community-dwelling older adults: A systematic review. J Clin Nurs. 2021;30:918–28. doi: 10.1111/jocn.15595.</cite> [<a href="https://doi.org/10.1111/jocn.15595" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33325067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Nurs&amp;title=Polypharmacy%20and%20pattern%20of%20medication%20use%20in%20community-dwelling%20older%20adults:%20A%20systematic%20review&amp;author=H-F%20Hsu&amp;author=K-M%20Chen&amp;author=F%20Belcastro&amp;volume=30&amp;publication_year=2021&amp;pages=918-28&amp;pmid=33325067&amp;doi=10.1111/jocn.15595&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Davies LE, Spiers G, Kingston A, et al.  Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J Am Med Dir Assoc. 2020;21:181–7. doi: 10.1016/j.jamda.2019.10.022.</cite> [<a href="https://doi.org/10.1016/j.jamda.2019.10.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31926797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Med%20Dir%20Assoc&amp;title=Adverse%20Outcomes%20of%20Polypharmacy%20in%20Older%20People:%20Systematic%20Review%20of%20Reviews&amp;author=LE%20Davies&amp;author=G%20Spiers&amp;author=A%20Kingston&amp;volume=21&amp;publication_year=2020&amp;pages=181-7&amp;pmid=31926797&amp;doi=10.1016/j.jamda.2019.10.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Fried TR, O’Leary J, Towle V, et al.  Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261–72. doi: 10.1111/jgs.13153.</cite> [<a href="https://doi.org/10.1111/jgs.13153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4270076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25516023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Geriatr%20Soc&amp;title=Health%20outcomes%20associated%20with%20polypharmacy%20in%20community-dwelling%20older%20adults:%20a%20systematic%20review&amp;author=TR%20Fried&amp;author=J%20O%E2%80%99Leary&amp;author=V%20Towle&amp;volume=62&amp;publication_year=2014&amp;pages=2261-72&amp;pmid=25516023&amp;doi=10.1111/jgs.13153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Wirtz VJ, Hogerzeil HV, Gray AL, et al.  Essential medicines for universal health coverage. Lancet. 2017;389:403–76. doi: 10.1016/S0140-6736(16)31599-9.</cite> [<a href="https://doi.org/10.1016/S0140-6736(16)31599-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7159295/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27832874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Essential%20medicines%20for%20universal%20health%20coverage&amp;author=VJ%20Wirtz&amp;author=HV%20Hogerzeil&amp;author=AL%20Gray&amp;volume=389&amp;publication_year=2017&amp;pages=403-76&amp;pmid=27832874&amp;doi=10.1016/S0140-6736(16)31599-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>World Health Organization  . Geneva: World Health Organization; 2002. Promoting rational use of medicines: core components.<a href="https://iris.who.int/handle/10665/67438" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://iris.who.int/handle/10665/67438</a> Available.</cite> [<a href="https://scholar.google.com/scholar_lookup?World%20Health%20Organization%20.%20Geneva:%20World%20Health%20Organization;%202002.%20Promoting%20rational%20use%20of%20medicines:%20core%20components.https://iris.who.int/handle/10665/67438%20Available." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Cahir C, Fahey T, Teeling M, et al.  Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69:543–52. doi: 10.1111/j.1365-2125.2010.03628.x.</cite> [<a href="https://doi.org/10.1111/j.1365-2125.2010.03628.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2856056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20573091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=Potentially%20inappropriate%20prescribing%20and%20cost%20outcomes%20for%20older%20people:%20a%20national%20population%20study&amp;author=C%20Cahir&amp;author=T%20Fahey&amp;author=M%20Teeling&amp;volume=69&amp;publication_year=2010&amp;pages=543-52&amp;pmid=20573091&amp;doi=10.1111/j.1365-2125.2010.03628.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Kamyari N, Soltanian AR, Mahjub H, et al.  Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data. Med J Islam Repub Iran. 2021;35:175.  doi: 10.47176/mjiri.35.175.</cite> [<a href="https://doi.org/10.47176/mjiri.35.175" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9127779/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35685196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med%20J%20Islam%20Repub%20Iran&amp;title=Mapping%20Drug%20Prescription,%20Polypharmacy,%20and%20Pharmaceutical%20Spending%20in%20Older%20Adults%20in%20Iran:%20A%20Multilevel%20Analysis%20Based%20on%20Claims%20Data&amp;author=N%20Kamyari&amp;author=AR%20Soltanian&amp;author=H%20Mahjub&amp;volume=35&amp;publication_year=2021&amp;pages=175&amp;pmid=35685196&amp;doi=10.47176/mjiri.35.175&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Karimi A, Haerizadeh M, Soleymani F, et al.  Evaluation of medicine prescription pattern using World Health Organization prescribing indicators in Iran: A cross-sectional study. J Res Pharm Pract. 2014;3:39–45. doi: 10.4103/2279-042X.137058.</cite> [<a href="https://doi.org/10.4103/2279-042X.137058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4124678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25114935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Res%20Pharm%20Pract&amp;title=Evaluation%20of%20medicine%20prescription%20pattern%20using%20World%20Health%20Organization%20prescribing%20indicators%20in%20Iran:%20A%20cross-sectional%20study&amp;author=A%20Karimi&amp;author=M%20Haerizadeh&amp;author=F%20Soleymani&amp;volume=3&amp;publication_year=2014&amp;pages=39-45&amp;pmid=25114935&amp;doi=10.4103/2279-042X.137058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Barnett K, Mercer SW, Norbury M, et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43. doi: 10.1016/S0140-6736(12)60240-2.</cite> [<a href="https://doi.org/10.1016/S0140-6736(12)60240-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22579043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Epidemiology%20of%20multimorbidity%20and%20implications%20for%20health%20care,%20research,%20and%20medical%20education:%20a%20cross-sectional%20study&amp;author=K%20Barnett&amp;author=SW%20Mercer&amp;author=M%20Norbury&amp;volume=380&amp;publication_year=2012&amp;pages=37-43&amp;pmid=22579043&amp;doi=10.1016/S0140-6736(12)60240-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Doshmangir L, Bazyar M, Rashidian A, et al.  Iran health insurance system in transition: equity concerns and steps to achieve universal health coverage. Int J Equity Health. 2021;20:37.  doi: 10.1186/s12939-020-01372-4.</cite> [<a href="https://doi.org/10.1186/s12939-020-01372-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7807408/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33446202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Equity%20Health&amp;title=Iran%20health%20insurance%20system%20in%20transition:%20equity%20concerns%20and%20steps%20to%20achieve%20universal%20health%20coverage&amp;author=L%20Doshmangir&amp;author=M%20Bazyar&amp;author=A%20Rashidian&amp;volume=20&amp;publication_year=2021&amp;pages=37&amp;pmid=33446202&amp;doi=10.1186/s12939-020-01372-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Iran Data Portal  Census 2016. 2016.  [12-Aug-2024]. <a href="https://irandataportal.syr.edu/census/census-2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://irandataportal.syr.edu/census/census-2016</a> Available. Accessed.</cite>
</li>
<li id="R15">
<span class="label">15.</span><cite>WHO collaborating centre for drug statistics methodology. ATC, structure and principles: Norwegian Institute of Public Health. 2024. <a href="https://atcddd.fhi.no/atc/structure_and_principles" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://atcddd.fhi.no/atc/structure_and_principles</a> Available.</cite>
</li>
<li id="R16">
<span class="label">16.</span><cite>Guillot J, Maumus-Robert S, Bezin J. Polypharmacy: A general review of definitions, descriptions and determinants. Therapie. 2020;75:407–16. doi: 10.1016/j.therap.2019.10.001.</cite> [<a href="https://doi.org/10.1016/j.therap.2019.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31732240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Therapie&amp;title=Polypharmacy:%20A%20general%20review%20of%20definitions,%20descriptions%20and%20determinants&amp;author=J%20Guillot&amp;author=S%20Maumus-Robert&amp;author=J%20Bezin&amp;volume=75&amp;publication_year=2020&amp;pages=407-16&amp;pmid=31732240&amp;doi=10.1016/j.therap.2019.10.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Al-Dahshan A, Al-Kubiasi N, Al-Zaidan M, et al.  Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study. PLoS One. 2020;15:e0234386.  doi: 10.1371/journal.pone.0234386.</cite> [<a href="https://doi.org/10.1371/journal.pone.0234386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7289385/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32525902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Prevalence%20of%20polypharmacy%20and%20the%20association%20with%20non-communicable%20diseases%20in%20Qatari%20elderly%20patients%20attending%20primary%20healthcare%20centers:%20A%20cross-sectional%20study&amp;author=A%20Al-Dahshan&amp;author=N%20Al-Kubiasi&amp;author=M%20Al-Zaidan&amp;volume=15&amp;publication_year=2020&amp;pages=e0234386&amp;pmid=32525902&amp;doi=10.1371/journal.pone.0234386&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Balkhi B, AlQahtani N, Alwhaibi M, et al.  Prevalence and Factors Associated With Polypharmacy Use Among Adult Patients in Saudi Arabia. J Patient Saf. 2021;17:e1119–24. doi: 10.1097/PTS.0000000000000439.</cite> [<a href="https://doi.org/10.1097/PTS.0000000000000439" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29087978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Patient%20Saf&amp;title=Prevalence%20and%20Factors%20Associated%20With%20Polypharmacy%20Use%20Among%20Adult%20Patients%20in%20Saudi%20Arabia&amp;author=B%20Balkhi&amp;author=N%20AlQahtani&amp;author=M%20Alwhaibi&amp;volume=17&amp;publication_year=2021&amp;pages=e1119-24&amp;pmid=29087978&amp;doi=10.1097/PTS.0000000000000439&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Kim H-A, Shin J-Y, Kim M-H, et al.  Prevalence and predictors of polypharmacy among Korean elderly. PLoS One. 2014;9:e98043.  doi: 10.1371/journal.pone.0098043.</cite> [<a href="https://doi.org/10.1371/journal.pone.0098043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4051604/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24915073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Prevalence%20and%20predictors%20of%20polypharmacy%20among%20Korean%20elderly&amp;author=H-A%20Kim&amp;author=J-Y%20Shin&amp;author=M-H%20Kim&amp;volume=9&amp;publication_year=2014&amp;pages=e98043&amp;pmid=24915073&amp;doi=10.1371/journal.pone.0098043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Ishizaki T, Mitsutake S, Hamada S, et al.  Drug prescription patterns and factors associated with polypharmacy in &gt;1 million older adults in Tokyo. Geriatrics Gerontology Int. 2020;20:304–11. doi: 10.1111/ggi.13880.</cite> [<a href="https://doi.org/10.1111/ggi.13880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32048453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Geriatrics%20Gerontology%20Int&amp;title=Drug%20prescription%20patterns%20and%20factors%20associated%20with%20polypharmacy%20in%20&gt;1%20million%20older%20adults%20in%20Tokyo&amp;author=T%20Ishizaki&amp;author=S%20Mitsutake&amp;author=S%20Hamada&amp;volume=20&amp;publication_year=2020&amp;pages=304-11&amp;pmid=32048453&amp;doi=10.1111/ggi.13880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Schneider R, Reinau D, Schur N, et al.  Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data. Swiss Med Wkly. 2019;149:w20126.  doi: 10.4414/smw.2019.20126.</cite> [<a href="https://doi.org/10.4414/smw.2019.20126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31568557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Swiss%20Med%20Wkly&amp;title=Drug%20prescription%20patterns,%20polypharmacy%20and%20potentially%20inappropriate%20medication%20in%20Swiss%20nursing%20homes:%20a%20descriptive%20analysis%20based%20on%20claims%20data&amp;author=R%20Schneider&amp;author=D%20Reinau&amp;author=N%20Schur&amp;volume=149&amp;publication_year=2019&amp;pages=w20126&amp;pmid=31568557&amp;doi=10.4414/smw.2019.20126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Badawy NA, Labeeb SA, Alsamdan MF, et al.  Prevalence and Risk of Polypharmacy among Community-Dwelling, Elderly Kuwaiti Patients. Med Princ Pract. 2020;29:166–73. doi: 10.1159/000503298.</cite> [<a href="https://doi.org/10.1159/000503298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7098304/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31509828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med%20Princ%20Pract&amp;title=Prevalence%20and%20Risk%20of%20Polypharmacy%20among%20Community-Dwelling,%20Elderly%20Kuwaiti%20Patients&amp;author=NA%20Badawy&amp;author=SA%20Labeeb&amp;author=MF%20Alsamdan&amp;volume=29&amp;publication_year=2020&amp;pages=166-73&amp;pmid=31509828&amp;doi=10.1159/000503298&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Chilet-Rosell E. Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs. Glob Health Action. 2014;7:25484.  doi: 10.3402/gha.v7.25484.</cite> [<a href="https://doi.org/10.3402/gha.v7.25484" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4262757/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25498360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Glob%20Health%20Action&amp;title=Gender%20bias%20in%20clinical%20research,%20pharmaceutical%20marketing,%20and%20the%20prescription%20of%20drugs&amp;author=E%20Chilet-Rosell&amp;volume=7&amp;publication_year=2014&amp;pages=25484&amp;pmid=25498360&amp;doi=10.3402/gha.v7.25484&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Morabia A, Fabre J, Dunand JP. The influence of patient and physician gender on prescription of psychotropic drugs. J Clin Epidemiol. 1992;45:111–6. doi: 10.1016/0895-4356(92)90003-6.</cite> [<a href="https://doi.org/10.1016/0895-4356(92)90003-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1573427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Epidemiol&amp;title=The%20influence%20of%20patient%20and%20physician%20gender%20on%20prescription%20of%20psychotropic%20drugs&amp;author=A%20Morabia&amp;author=J%20Fabre&amp;author=JP%20Dunand&amp;volume=45&amp;publication_year=1992&amp;pages=111-6&amp;pmid=1573427&amp;doi=10.1016/0895-4356(92)90003-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Khajeh A, Vardanjani HM, Salehi A, et al.  Healthcare-seeking behavior and its relating factors in South of Iran. J Educ Health Promot. 2019;8:183.  doi: 10.4103/jehp.jehp_93_19.</cite> [<a href="https://doi.org/10.4103/jehp.jehp_93_19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6796318/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31867368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Educ%20Health%20Promot&amp;title=Healthcare-seeking%20behavior%20and%20its%20relating%20factors%20in%20South%20of%20Iran&amp;author=A%20Khajeh&amp;author=HM%20Vardanjani&amp;author=A%20Salehi&amp;volume=8&amp;publication_year=2019&amp;pages=183&amp;pmid=31867368&amp;doi=10.4103/jehp.jehp_93_19&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Marzban M, Jamshidi A, Khorrami Z, et al.  Determinants of multimorbidity in older adults in Iran: a cross-sectional study using latent class analysis on the Bushehr Elderly Health (BEH) program. BMC Geriatr. 2024;24:247.  doi: 10.1186/s12877-024-04848-y.</cite> [<a href="https://doi.org/10.1186/s12877-024-04848-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10929162/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38468227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Geriatr&amp;title=Determinants%20of%20multimorbidity%20in%20older%20adults%20in%20Iran:%20a%20cross-sectional%20study%20using%20latent%20class%20analysis%20on%20the%20Bushehr%20Elderly%20Health%20(BEH)%20program&amp;author=M%20Marzban&amp;author=A%20Jamshidi&amp;author=Z%20Khorrami&amp;volume=24&amp;publication_year=2024&amp;pages=247&amp;pmid=38468227&amp;doi=10.1186/s12877-024-04848-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Onder G, Marengoni A, Russo P, et al.  Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency. J Am Med Dir Assoc. 2016;17:168–72. doi: 10.1016/j.jamda.2015.08.009.</cite> [<a href="https://doi.org/10.1016/j.jamda.2015.08.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26441359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Med%20Dir%20Assoc&amp;title=Advanced%20Age%20and%20Medication%20Prescription:%20More%20Years,%20Less%20Medications?%20A%20Nationwide%20Report%20From%20the%20Italian%20Medicines%20Agency&amp;author=G%20Onder&amp;author=A%20Marengoni&amp;author=P%20Russo&amp;volume=17&amp;publication_year=2016&amp;pages=168-72&amp;pmid=26441359&amp;doi=10.1016/j.jamda.2015.08.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Cherubini A, Corsonello A, Lattanzio F. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging. 2012;29:463–75. doi: 10.2165/11631750-000000000-00000.</cite> [<a href="https://doi.org/10.2165/11631750-000000000-00000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22642781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs%20Aging&amp;title=Underprescription%20of%20beneficial%20medicines%20in%20older%20people:%20causes,%20consequences%20and%20prevention&amp;author=A%20Cherubini&amp;author=A%20Corsonello&amp;author=F%20Lattanzio&amp;volume=29&amp;publication_year=2012&amp;pages=463-75&amp;pmid=22642781&amp;doi=10.2165/11631750-000000000-00000&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Eskandari M, Abbaszadeh A, Borhani F. The outcomes of health care process in Iran’s rural society. Iran J Nurs Midwifery Res. 2013;18:384–90.</cite> [<a href="/articles/PMC3877461/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24403941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Iran%20J%20Nurs%20Midwifery%20Res&amp;title=The%20outcomes%20of%20health%20care%20process%20in%20Iran%E2%80%99s%20rural%20society&amp;author=M%20Eskandari&amp;author=A%20Abbaszadeh&amp;author=F%20Borhani&amp;volume=18&amp;publication_year=2013&amp;pages=384-90&amp;pmid=24403941&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Mohaqeqi Kamal SH, Basakha M, Department of Social Welfare Management, Faculty of Educational Sciences and Social Welfare, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. et al.  Prevalence of Chronic Diseases Among the Older Adults in Iran: Does Socioeconomic Status Matter? 
Salmand
. 2022;16:468–81. doi: 10.32598/sija.2022.16.4.767.2.</cite> [<a href="https://doi.org/10.32598/sija.2022.16.4.767.2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Salmand&amp;title=Prevalence%20of%20Chronic%20Diseases%20Among%20the%20Older%20Adults%20in%20Iran:%20Does%20Socioeconomic%20Status%20Matter?&amp;author=SH%20Mohaqeqi%20Kamal&amp;author=M%20Basakha&amp;volume=16&amp;publication_year=2022&amp;pages=468-81&amp;doi=10.32598/sija.2022.16.4.767.2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Saboor M, Momtaz YA, Kamrani A-AA, et al.  Prescription pattern among Iranian community dwelling older adults. Med Glas (Zenica) 2019;16:115–20. doi: 10.17392/986-19.</cite> [<a href="https://doi.org/10.17392/986-19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30680985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med%20Glas%20(Zenica)&amp;title=Prescription%20pattern%20among%20Iranian%20community%20dwelling%20older%20adults&amp;author=M%20Saboor&amp;author=YA%20Momtaz&amp;author=A-AA%20Kamrani&amp;volume=16&amp;publication_year=2019&amp;pages=115-20&amp;pmid=30680985&amp;doi=10.17392/986-19&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Mohsenzadeh P, Ardekani A, Poustchi H, et al.  Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran. BMC Cardiovasc Disord. 2022;22:435.  doi: 10.1186/s12872-022-02872-7.</cite> [<a href="https://doi.org/10.1186/s12872-022-02872-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9536013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36203125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cardiovasc%20Disord&amp;title=Population-based%20pattern%20of%20medication%20use%20and%20prevalence%20of%20polypharmacy%20among%20patients%20with%20cardiovascular%20diseases:%20results%20of%20the%20Pars%20cohort%20study%20from%20Iran&amp;author=P%20Mohsenzadeh&amp;author=A%20Ardekani&amp;author=H%20Poustchi&amp;volume=22&amp;publication_year=2022&amp;pages=435&amp;pmid=36203125&amp;doi=10.1186/s12872-022-02872-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Imam AP, Halpern GM. Uses, adverse effects of abuse of corticosteroids. Part I. Allergol Immunopathol (Madr) 1994;22:250–60.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7892813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Allergol%20Immunopathol%20(Madr)&amp;title=Uses,%20adverse%20effects%20of%20abuse%20of%20corticosteroids.%20Part%20I&amp;author=AP%20Imam&amp;author=GM%20Halpern&amp;volume=22&amp;publication_year=1994&amp;pages=250-60&amp;pmid=7892813&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Yousefi N, Majdzadeh R, Valadkhani M, et al.  Reasons for physicians’ tendency to irrational prescription of corticosteroids. Iran Red Crescent Med J. 2012;14:713–8. doi: 10.5812/ircmj.2284.</cite> [<a href="https://doi.org/10.5812/ircmj.2284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3560541/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23396638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Iran%20Red%20Crescent%20Med%20J&amp;title=Reasons%20for%20physicians%E2%80%99%20tendency%20to%20irrational%20prescription%20of%20corticosteroids&amp;author=N%20Yousefi&amp;author=R%20Majdzadeh&amp;author=M%20Valadkhani&amp;volume=14&amp;publication_year=2012&amp;pages=713-8&amp;pmid=23396638&amp;doi=10.5812/ircmj.2284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Brownlee S, Chalkidou K, Doust J, et al.  Evidence for overuse of medical services around the world. Lancet. 2017;390:156–68. doi: 10.1016/S0140-6736(16)32585-5.</cite> [<a href="https://doi.org/10.1016/S0140-6736(16)32585-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5708862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28077234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Evidence%20for%20overuse%20of%20medical%20services%20around%20the%20world&amp;author=S%20Brownlee&amp;author=K%20Chalkidou&amp;author=J%20Doust&amp;volume=390&amp;publication_year=2017&amp;pages=156-68&amp;pmid=28077234&amp;doi=10.1016/S0140-6736(16)32585-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Scott IA, Hilmer SN, Reeve E, et al.  Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175:827–34. doi: 10.1001/jamainternmed.2015.0324.</cite> [<a href="https://doi.org/10.1001/jamainternmed.2015.0324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25798731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Intern%20Med&amp;title=Reducing%20inappropriate%20polypharmacy:%20the%20process%20of%20deprescribing&amp;author=IA%20Scott&amp;author=SN%20Hilmer&amp;author=E%20Reeve&amp;volume=175&amp;publication_year=2015&amp;pages=827-34&amp;pmid=25798731&amp;doi=10.1001/jamainternmed.2015.0324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Marengoni A, Onder G. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ. 2015;350:h1059.  doi: 10.1136/bmj.h1059.</cite> [<a href="https://doi.org/10.1136/bmj.h1059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25761379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Guidelines,%20polypharmacy,%20and%20drug-drug%20interactions%20in%20patients%20with%20multimorbidity&amp;author=A%20Marengoni&amp;author=G%20Onder&amp;volume=350&amp;publication_year=2015&amp;pages=h1059&amp;pmid=25761379&amp;doi=10.1136/bmj.h1059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Scott I, Jayathissa S. Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J. 2010;40:7–18. doi: 10.1111/j.1445-5994.2009.02040.x.</cite> [<a href="https://doi.org/10.1111/j.1445-5994.2009.02040.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19712203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Intern%20Med%20J&amp;title=Quality%20of%20drug%20prescribing%20in%20older%20patients:%20is%20there%20a%20problem%20and%20can%20we%20improve%20it?&amp;author=I%20Scott&amp;author=S%20Jayathissa&amp;volume=40&amp;publication_year=2010&amp;pages=7-18&amp;pmid=19712203&amp;doi=10.1111/j.1445-5994.2009.02040.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Wehling M, Petrovic M. Deprescribing or represcribing: not just a semantic dilemma. Eur Geriatr Med. 2022;13:529–30. doi: 10.1007/s41999-021-00583-4.</cite> [<a href="https://doi.org/10.1007/s41999-021-00583-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9151539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34738225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Geriatr%20Med&amp;title=Deprescribing%20or%20represcribing:%20not%20just%20a%20semantic%20dilemma&amp;author=M%20Wehling&amp;author=M%20Petrovic&amp;volume=13&amp;publication_year=2022&amp;pages=529-30&amp;pmid=34738225&amp;doi=10.1007/s41999-021-00583-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="sub-article1"><section class="pmc-layout__citation font-secondary font-xs"><div>BMJ Open. 2025 Aug 21.</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Review Process File</h1></hgroup><ul class="d-buttons inline-list"><li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li></ul>
<div class="d-panels font-secondary-light"><div id="clp_a.c" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div></div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<figure class="fig xbox font-sm" id="d67e3452"><div class="media p"><div class="caption">
<a href="/articles/instance/12374635/bin/bmjopen-2024-097863.reviewer_comments.pdf" data-ga-action="click_feat_suppl" class="usa-link">bmjopen-2024-097863.reviewer_comments.pdf</a><sup> (295.1KB, pdf) </sup>
</div></div>
<div class="p text-right font-secondary"><a href="figure/d67e3452/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data are available on reasonable request.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMJ Open are provided here courtesy of <strong>BMJ Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1136/bmjopen-2024-097863"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/bmjopen-15-8.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374635/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374635/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374635%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374635/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374635/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374635/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40840984/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374635/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40840984/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374635/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374635/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="epbLsqdO7VpSVQfZNbcFKbQwIOc3lh4lDkHrPZqhxQdQgU9gylIVkPJ8wtCH0fTd">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
